-
The R&D of CD20/CD3 Bispecific Antibody in China
Yefenghong/PharmaSources
March 01, 2023
Currently, the R&D of CD20/CD3 bispecific antibody is still in the early stage. In China, few CD20/CD3 bispecific antibodies have entered the clinical stage, among which GB261 from Genor Biopharma has a good progress.
-
Weekly Pharma News Review | PharmaSources.com (May.6th to May.15th)
PharmaSources.com
May 18, 2022
The most encouraging news this week is that the international, multicenter, Phase III clinical trials of Hengrui's PD-1 combination therapy for liver cancer have been announced to be successful.
-
Avantor Named Best Bioprocessing Company in Chromatography at the Asia-Pacific Bioprocessing Excellence Awards
PharmaSources
March 16, 2023
Industry panel recognizes Avantor's outstanding accomplishments in chromatography instruments, chemicals, and consumables.
-
Sustainability vs single-use-tech: how COVID-19 has made biopharma more sustainable
CPhIonline
February 09, 2022
COVID-19 saw biopharma turn to single-use technology in a big way. But greater use of disposable manufacturing systems does not necessarily mean drug and vaccine production has become less environmentally sustainable.
-
INCOG BioPharma Services Builds State-of-the-Art Facility
contractpharma
January 13, 2022
Nearing completion on the construction of a 90,000 sq. ft. manufacturing facility and global headquarters in Fishers,
Indiana.
-
Cato SMS, Pharm-Olam Merge to Create Global Biopharma Services Company
contractpharma
January 07, 2022
Newly combined company positioned to serve small and mid-sized biopharmaceutical companies.
-
Terracon Acquired by ChargePoint Technology
contractpharma
January 05, 2022
Acquisition will further support the customers of ChargePoint Technology and Terracon collectively.
-
Freudenberg to introduce products in 2022 focussed on fluid-handling space for biopharma
ExpressPharma
November 25, 2021
Freudenberg Medical has been serving biopharma customers directly, and with the help of a few distributors in India for the past few years, supplying standard and custom silicone tubings and fluid-handling products...
-
Lonza extends collaboration with biopharma client for antibody drug conjugate supply
expresspharma
July 19, 2021
Lonza Group has extended collaboration with a major biopharma industry client for the supply of an antibody drug conjugate (ADC) against hard-to-treat cancers, the company said in a statement.
-
NIIMBL Announces $4.6M to Fund 10 New Biopharmaceutical Manufacturing Projects
americanpharmaceuticalreview
June 10, 2021
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced funding for 10 new projects in technology, workforce development, and their Global Health Fund initiative, resulting from the Institute's Project Call 4.1 ...